These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


945 related items for PubMed ID: 11524468

  • 1. A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease.
    Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E, Donepezil MSAD Study Investigators Group.
    Neurology; 2001 Aug 28; 57(4):613-20. PubMed ID: 11524468
    [Abstract] [Full Text] [Related]

  • 2. Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease.
    Gauthier S, Feldman H, Hecker J, Vellas B, Emir B, Subbiah P, Donepezil MSAD Study Investigators' Group.
    Curr Med Res Opin; 2002 Aug 28; 18(6):347-54. PubMed ID: 12442882
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
    Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR, Schwam EM, Donepezil MSAD Study Investigators Group.
    Int J Geriatr Psychiatry; 2005 Jun 28; 20(6):559-69. PubMed ID: 15920715
    [Abstract] [Full Text] [Related]

  • 4. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.
    J Am Geriatr Soc; 2001 Dec 28; 49(12):1590-9. PubMed ID: 11843990
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study.
    Farlow MR, Salloway S, Tariot PN, Yardley J, Moline ML, Wang Q, Brand-Schieber E, Zou H, Hsu T, Satlin A.
    Clin Ther; 2010 Jul 28; 32(7):1234-51. PubMed ID: 20678673
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden.
    Feldman H, Gauthier S, Hecker J, Vellas B, Emir B, Mastey V, Subbiah P, Donepezil MSAD Study Investigators Group.
    J Am Geriatr Soc; 2003 Jun 28; 51(6):737-44. PubMed ID: 12757558
    [Abstract] [Full Text] [Related]

  • 7. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Black SE, Doody R, Li H, McRae T, Jambor KM, Xu Y, Sun Y, Perdomo CA, Richardson S.
    Neurology; 2007 Jul 31; 69(5):459-69. PubMed ID: 17664405
    [Abstract] [Full Text] [Related]

  • 8. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.
    Rogers SL, Doody RS, Mohs RC, Friedhoff LT.
    Arch Intern Med; 1998 May 11; 158(9):1021-31. PubMed ID: 9588436
    [Abstract] [Full Text] [Related]

  • 9. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.
    Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I, Memantine Study Group.
    JAMA; 2004 Jan 21; 291(3):317-24. PubMed ID: 14734594
    [Abstract] [Full Text] [Related]

  • 10. Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.
    Winblad B, Kilander L, Eriksson S, Minthon L, Båtsman S, Wetterholm AL, Jansson-Blixt C, Haglund A, Severe Alzheimer's Disease Study Group.
    Lancet; 2006 Apr 01; 367(9516):1057-1065. PubMed ID: 16581404
    [Abstract] [Full Text] [Related]

  • 11. The effects of donepezil in Alzheimer's disease - results from a multinational trial.
    Burns A, Rossor M, Hecker J, Gauthier S, Petit H, Möller HJ, Rogers SL, Friedhoff LT.
    Dement Geriatr Cogn Disord; 1999 Apr 01; 10(3):237-44. PubMed ID: 10325453
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of donepezil in patients with Alzheimer's disease: results of a global, multinational, clinical experience study.
    Boada-Rovira M, Brodaty H, Cras P, Baloyannis S, Emre M, Zhang R, Bahra R, 322 Study Group.
    Drugs Aging; 2004 Apr 01; 21(1):43-53. PubMed ID: 14715043
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
    Black S, Román GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, Kumar D, Pratt R, Donepezil 307 Vascular Dementia Study Group.
    Stroke; 2003 Oct 01; 34(10):2323-30. PubMed ID: 12970516
    [Abstract] [Full Text] [Related]

  • 17. Donepezil for vascular cognitive impairment.
    Malouf R, Birks J.
    Cochrane Database Syst Rev; 2004 Oct 01; (1):CD004395. PubMed ID: 14974068
    [Abstract] [Full Text] [Related]

  • 18. Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial.
    Mori E, Ikeda M, Kosaka K, Donepezil-DLB Study Investigators.
    Ann Neurol; 2012 Jul 01; 72(1):41-52. PubMed ID: 22829268
    [Abstract] [Full Text] [Related]

  • 19. Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology.
    Touchon J, Bergman H, Bullock R, Rapatz G, Nagel J, Lane R.
    Curr Med Res Opin; 2006 Jan 01; 22(1):49-59. PubMed ID: 16393430
    [Abstract] [Full Text] [Related]

  • 20. Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial.
    Homma A, Imai Y, Tago H, Asada T, Shigeta M, Iwamoto T, Takita M, Arimoto I, Koma H, Ohbayashi T.
    Dement Geriatr Cogn Disord; 2008 Jan 01; 25(5):399-407. PubMed ID: 18391486
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 48.